BORGOGNA, Cinzia
 Distribuzione geografica
Continente #
EU - Europa 2.091
NA - Nord America 2.015
AS - Asia 1.690
SA - Sud America 270
AF - Africa 44
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.117
Nazione #
US - Stati Uniti d'America 1.951
SG - Singapore 586
RU - Federazione Russa 543
CN - Cina 374
IE - Irlanda 329
DE - Germania 300
VN - Vietnam 276
IT - Italia 228
BR - Brasile 213
HK - Hong Kong 213
SE - Svezia 196
UA - Ucraina 139
FR - Francia 110
FI - Finlandia 66
IN - India 60
GB - Regno Unito 55
KR - Corea 49
CA - Canada 35
CZ - Repubblica Ceca 31
BD - Bangladesh 27
MX - Messico 24
TR - Turchia 24
AR - Argentina 20
ID - Indonesia 18
ZA - Sudafrica 16
AT - Austria 15
ES - Italia 15
NL - Olanda 15
PL - Polonia 14
BE - Belgio 13
BJ - Benin 13
CO - Colombia 12
IR - Iran 11
JP - Giappone 8
EC - Ecuador 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
PK - Pakistan 6
CL - Cile 5
LT - Lituania 5
PE - Perù 5
SA - Arabia Saudita 5
TH - Thailandia 4
AU - Australia 3
HR - Croazia 3
LV - Lettonia 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MR - Mauritania 2
SR - Suriname 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NR - Nauru 1
OM - Oman 1
PW - Palau 1
SI - Slovenia 1
YE - Yemen 1
Totale 6.117
Città #
Dublin 327
San Jose 235
Jacksonville 229
Hong Kong 213
Singapore 153
Dearborn 146
Chandler 134
Beijing 124
Ashburn 104
Ho Chi Minh City 89
Los Angeles 89
Ann Arbor 59
Hanoi 53
Moscow 51
Wilmington 48
Council Bluffs 47
Seoul 45
Lauterbourg 44
Lawrence 43
Princeton 43
Munich 42
New York 42
Piemonte 39
San Mateo 36
Brno 31
Novara 30
Bremen 24
Frankfurt am Main 24
Buffalo 22
Santa Clara 21
São Paulo 21
Milan 19
Orem 19
Haiphong 17
Toronto 16
Düsseldorf 15
Nuremberg 15
Andover 14
Chennai 14
Dallas 14
Genoa 14
Helsinki 14
Boardman 13
Brussels 13
Cotonou 13
Guangzhou 13
Da Nang 12
London 12
Redondo Beach 12
Turin 12
Amsterdam 11
Denver 11
Grafing 11
Hefei 11
Johannesburg 11
Tianjin 11
Warsaw 11
Columbus 10
Houston 10
Nanjing 10
Woodbridge 10
Brooklyn 9
Jakarta 9
Dong Ket 8
Mexico City 8
Montreal 8
Poplar 8
Rio de Janeiro 8
Atlanta 7
Hangzhou 7
Manchester 7
Monmouth Junction 7
Nanchang 7
Tokyo 7
Biên Hòa 6
Boston 6
Can Tho 6
Kunming 6
Leawood 6
Mumbai 6
Norwalk 6
Querétaro 6
San Francisco 6
Turku 6
Buenos Aires 5
Fairfield 5
Falkenstein 5
Medellín 5
Paris 5
Rome 5
Seattle 5
Tornaco 5
Vienna 5
Zhengzhou 5
Ankara 4
Ardabil 4
Augusta 4
Baghdad 4
Belo Horizonte 4
Calgary 4
Totale 3.230
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 276
HPV E7 Oncoprotein Subverts Host Innate Immunity Via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes 183
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling 180
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 172
β-HPV Infection Correlates with Early Stages of Carcinogenesis in Skin Tumors and Patient-Derived Xenografts from a Single Center Kidney Transplant Recipient Cohort 160
Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells. 148
Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases 148
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution 140
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 135
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models 135
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion 134
Characterization of skin lesions induced by skin-tropic α- and β-papillomaviruses in a patient with epidermodysplasia verruciformis 133
Alpha- and Beta-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions. 133
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 131
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 130
Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients. 130
HPV-induced field cancerisation: Transformation of adult tissue stem cell into cancer stem cell 130
Primary trichodysplasia spinulosa polyomavirus infection in a kidney transplant child displaying virus-infected decoy cells in the urine 126
Evidence of BK Polyomavirus Infection in Urothelial but not Renal Tumors from a Single Center Cohort of Kidney Transplant Recipients 126
Identification of the skin virome in a young boy with widespread HPV2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine 122
Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene 120
Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties. 119
TRICHODYSPLASIA SPINULOSA IN A KIDNEY TRANSPLANT RECIPIENT WITH CONCURRENT JC, BK, AND TSPYV VIRURIA AND DECOY OR DEGENERATED CELLS 119
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story 119
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 116
The nuclear DNA sensor IFN-inducible protein 16 (IFI16) acts as restriction factor for human papillomavirus replication 116
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 115
Restriction of HPV18 Replication in the Nucleus by IFI16: what about Innate Sensing? 114
Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations 113
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 113
Metagenomic discovery of 83 new human papillomavirus types in patients with immunodeficiency 112
HumanBeta-papillomavirus infection and keratinocyte carcinomas 110
Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING 110
A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine 106
Cancer-Associated Fibroblasts Exert Proangiogenic Activity in Merkel Cell Carcinoma 106
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study 105
#Stayathome If You Have a Cold: High SARS-CoV-2 Salivary Viral Loads in Pediatric Patients with Nasopharyngeal Symptoms 104
SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy 102
The intracellular DNA sensor IFI16 gene acts as a restriction factor for human papillomavirus replication 91
Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of auto antigen processing. BORGOGNA C. CO-FIRST AUTHOR 90
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles 89
No indications for HPV involvement in the hypertrophic skin lesions of a Darier disease case without ATP2A2 gene mutations 89
Keratinocyte-Specific Stat3 Heterozygosity Impairs Development of Skin Tumors in Human Papillomavirus 8 Transgenic Mice 88
The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 88
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. 85
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 85
Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed Human Papillomavirus Type 8‒Transgenic Mice 82
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity 79
Identification of Defective Fas Function and Variation of the Perforin Gene in an Epidermodysplasia Verruciformis Patient Lacking EVER1 and EVER2 Mutations 78
Longitudinal monitoring of SARS-CoV-2 viral load in self-collected saliva from health care workers during breakthrough infections to spare working days 75
HPV8-induced STAT3 activation led keratinocyte stem cell expansion in human actinic keratoses 73
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16 70
Convergent evolution of the G3BP1-binding motif in betacoronavirus nucleocapsid proteins 41
IFI16 restricts SARS-CoV-2 replication by disrupting nucleocapsid-driven phase separation 6
Totale 6.200
Categoria #
all - tutte 27.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022362 15 18 41 42 16 5 23 13 16 22 56 95
2022/2023833 48 37 63 14 63 87 22 65 368 4 28 34
2023/2024396 39 21 29 7 37 8 90 7 2 7 89 60
2024/2025900 31 11 39 19 55 18 60 77 176 57 115 242
2025/20262.636 139 125 204 425 212 174 364 414 179 199 159 42
Totale 6.200